Log In
BCIQ
Print this Print this
 

AK002

  Manage Alerts
Collapse Summary General Information
Company Allakos Inc.
DescriptionUndisclosed antibody that induces the killing of mast cells and eosinophils
Molecular Target Undisclosed
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase I
Standard Indication Hematology (unspecified)
Indication DetailsTreat indolent systemic mastocytosis
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today